Efficacy and safety of camrelizumab in combination with radiation and chemotherapy for recurrent or metastatic cervical cancer

被引：0
|
作者：
Chen, Zhongjie
Yan, Bo
Xu, Liming
Huang, Xin
Li, Meng
Wang, Jun
Zhu, Li
Yuan, Zhiyong
Wang, Ping
机构：
[1] Tianjin Med Univ Canc Hosp & Inst, Tianjin, Peoples R China
[2] Tianjin Canc Hosp Airport Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5542
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF BEVACIZUMAB COMBINATION CHEMOTHERAPY FOR RECURRENT CERVICAL CANCER
    Kusakabe, M.
    Tanikawa, M.
    Oda, K.
    Nagasaka, K.
    Miyamoto, Y.
    Sone, K.
    Mori, M.
    Tsuruga, T.
    Matsumoto, Y.
    Osuga, Y.
    Fujii, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 318 - 318
  • [2] Camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy in women with recurrent or metastatic cervical cancer
    Wu, X.
    Xia, L.
    Zhang, K.
    Tang, Y.
    Zhang, G. N.
    Wang, D.
    Lou, H.
    Liu, N.
    Zhang, H.
    Chen, H.
    Wang, K.
    Wei, S.
    Wang, L.
    Gao, K.
    Li, G.
    Zhang, H.
    Hu, Y.
    Zhou, X.
    Wang, Y.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S1284 - S1285
  • [3] Chemotherapy in recurrent and metastatic cervical cancer: single agent versus combination chemotherapy
    Kumar, L
    Pokharel, YH
    Kumar, S
    Singh, R
    Rath, GK
    Kochupillai, V
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1225 - 1228
  • [4] The efficacy and safety of addition of bevacizumab to combination chemotherapy in patients with persistent, recurrent, or metastatic cervical cancer: Single institute experiences in Korea
    Lee, Y. J.
    Kim, Y. M.
    Mok, J. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 391 - 391
  • [5] Chemotherapy for metastatic and recurrent cervical cancer
    Scatchard, Kate
    Forrest, Jennifer L.
    Flubacher, Maxine
    Cornes, Paul
    Williams, Chris
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [6] Chemotherapy for recurrent and metastatic cervical cancer
    Tao, Xia
    Hu, Wei
    Ramirez, Pedro T.
    Kavanagh, John J.
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : S67 - S71
  • [7] The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer
    Minion, Lindsey E.
    Tewari, Krishnansu S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (03) : 191 - 198
  • [8] Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
    Ercelep, Ozlem
    Tataroglu, Deniz
    Ozcelik, Melike
    Surmeli, Heves
    Degirmenci, Mustafa
    Inanc, Mevlude
    Aliustaoglu, Mehmet
    Gumus, Mahmut
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 17 (02) : 123 - 127
  • [9] Bevacizumab plus chemotherapy versus combination chemotherapy only in metastatic, recurrent, and persistent cervical cancer
    Choi, H.
    Kim, B. G.
    Lee, Y. Y.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 275 - 275
  • [10] Efficacy and Safety of Local Radiotherapy Combined with Chemotherapy Bevacizumab in the Treatment of Patients with Advanced and Recurrent Metastatic Cervical Cancer
    Hu, L.
    Fenghu, L.
    Li, J.
    Du, Y.
    Mei, F.
    Tian, X.
    Qin, Y.
    Lu, B.
    Shan, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E512 - E513
12345